Role of endoscopic ultrasound fine-needle aspiration evaluating adrenal gland enlargement or mass

dc.contributor.authorMartinez, Melissa
dc.contributor.authorLeBlanc, Julia
dc.contributor.authorAl-Haddad, Mohammad
dc.contributor.authorSherman, Stuart
dc.contributor.authorDeWitt, John
dc.contributor.departmentDepartment of Medicine, IU School of Medicineen_US
dc.date.accessioned2015-11-03T16:10:32Z
dc.date.available2015-11-03T16:10:32Z
dc.date.issued2014-08-06
dc.description.abstractAIM: To report the clinical impact of adrenal endoscopic ultrasound fine-needle aspiration (EUS-FNA) in the evaluation of patients with adrenal gland enlargement or mass. METHODS: In a retrospective single-center case-series, patients undergoing EUS-FNA of either adrenal gland from 1997-2011 in our tertiary care center were included. Medical records were reviewed and results of EUS, cytology, adrenal size change on follow-up imaging ≥ 6 mo after EUS and any repeat EUS or surgery were abstracted. A lesion was considered benign if: (1) EUS-FNA cytology was benign and the lesion remained < 1 cm from its original size on follow-up computed tomography (CT), magnetic resonance imaging or repeat EUS ≥ 6 mo after EUS-FNA; or (2) subsequent adrenalectomy and surgical pathology was benign. RESULTS: Ninety-four patients had left (n = 90) and/or right (n = 5) adrenal EUS-FNA without adverse events. EUS indications included: cancer staging or suspected recurrence (n = 31), pancreatic (n = 20), mediastinal (n = 10), adrenal (n = 7), lung (n = 7) mass or other indication (n = 19). Diagnoses after adrenal EUS-FNA included metastatic lung (n = 10), esophageal (n= 5), colon (n = 2), or other cancer (n = 8); benign primary adrenal mass or benign tissue (n = 60); or was non-diagnostic (n = 9). Available follow-up confirmed a benign lesion in 5/9 non-diagnostic aspirates and 32/60 benign aspirates. Four of the 60 benign aspirates were later confirmed as malignant by repeat biopsy, follow-up CT, or adrenalectomy. Adrenal EUS-FNA diagnosed metastatic cancer in 24, and ruled out metastasis in 10 patients. For the diagnosis of malignancy, EUS-FNA of either adrenal had sensitivity, specificity, positive predictive value and negative predictive value of 86%, 97%, 96% and 89%, respectively. CONCLUSION: Adrenal gland EUS-FNA is safe, minimally invasive and a sensitive technique with significant impact in the management of adrenal gland mass or enlargement.en_US
dc.identifier.citationMartinez, M., LeBlanc, J., Al-Haddad, M., Sherman, S., & DeWitt, J. (2014). Role of endoscopic ultrasound fine-needle aspiration evaluating adrenal gland enlargement or mass. World Journal of Nephrology, 3(3), 92–100. http://doi.org/10.5527/wjn.v3.i3.92en_US
dc.identifier.urihttps://hdl.handle.net/1805/7322
dc.language.isoen_USen_US
dc.publisherBaishideng Publishing Group Inc.en_US
dc.relation.isversionof10.5527/wjn.v3.i3.92en_US
dc.relation.journalWorld Journal of Nephrologyen_US
dc.rightsAttribution-NonCommercial 3.0 United States
dc.rights.urihttps://creativecommons.org/licenses/by-nc/3.0/us
dc.sourcePMCen_US
dc.subjectAdrenal gland neoplasms/diagnosisen_US
dc.subjectAdrenal glands/pathologyen_US
dc.subjectAdrenal gland/ultrasonographyen_US
dc.subjectAdrenal gland neoplasms/secondaryen_US
dc.subjectEndosonographyen_US
dc.subjectBiopsyen_US
dc.subjectFine-needleen_US
dc.titleRole of endoscopic ultrasound fine-needle aspiration evaluating adrenal gland enlargement or massen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
WJN-3-92.pdf
Size:
873.11 KB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description: